Evidence map›Paper›PMID 21039464›Full record

ArticleImmunology2011

Activation of p38 mitogen-activated protein kinase by norepinephrine in T-lineage cells.

Melissa D Lajevic, Samia Suleiman, Rhonna L Cohen, Donald A Chambers

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Functional p38 MAPK identified by biomarker profiling of pancreatic cancer restrains growth through JNK inhibition and correlates with improved survival.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Melissa D LajevicDepartment of Bioengineering, University of Illinois at Chicago, Chicago, IL 60612, USA.
Samia Suleiman
Rhonna L Cohen
Donald A Chambers
University of Illinois Chicago · US

Funding

MOLECULAR MECHANISMS OF STRESS-RELATED ORAL DISEASESR01DE013684 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHAMBERS, DONALD A · 2002 to 2006
$1.6M
NIAID NIH HHS R01 DE/AI 13684NIDCR NIH HHS R01 DE013684
6 · The paper itself

Abstract

The catecholamine norepinephrine (NE) stimulates T lymphocytes through a beta-adrenergic receptor (βAR)/adenylyl cyclase (AC)/cyclic AMP (cAMP)/protein kinase A (PKA) pathway, leading to altered cell responsiveness and apoptosis. p38 Mitogen-activated protein kinase (MAPK), a major intracellular signalling mediator for cellular and environmental stressors, is involved in the production of immune modulators and in the regulation of T-cell development, survival and death. In these studies we investigated the relationship among NE signalling, p38 MAPK activity and T-cell death. We showed that NE stimulation of BALB/c mouse thymocytes and S49 thymoma cells selectively increases the dual phosphorylation and activity of p38α MAPK. p38 MAPK activation involves the βAR, Gs protein, AC, cAMP and PKA, as determined through the use of a βAR antagonist, activators of AC and cAMP, and S49 clonal mutants deficient in Gs and PKA. Dual phosphorylation of p38 MAPK is also dependent on its own catalytic activity. Inhibition of p38 MAPK activity revealed its involvement in cAMP-mediated activating transcription factor-2 (ATF-2) phosphorylation, Fas ligand messenger RNA (mRNA) up-regulation, and cell death. These results identify a mechanism through which NE stimulation of the βAR/Gs/PKA pathway activates p38 MAPK, which can be potentiated by autophosphorylation, and leads to changes in T-cell dynamics, in part through the regulation of Fas ligand mRNA expression.

Indexed as

Signal TransductionAnimalsApoptosisCells, CulturedCyclic AMP-Dependent Protein KinasesEnzyme ActivationFas Ligand ProteinGTP-Binding Protein alpha Subunits, GsLymphocyte ActivationMaleMiceMice, Inbred BALB CNorepinephrinep38 Mitogen-Activated Protein KinasesReceptors, Adrenergic, betaRNA, MessengerCyclic AMP-Dependent Protein KinasesFas Ligand ProteinGTP-Binding Protein alpha Subunits, GsNorepinephrinep38 Mitogen-Activated Protein KinasesReceptors, Adrenergic, betaRNA, Messenger

Identifiers

PMID21039464
PMCPMC3050443
OpenAlexW1490003551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.